Perrigo Co: (NASD: PRGO)

$118.07

-0.58 (-0.49%)

Volume 504,348

May 22 04:00 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		117.25 - 120.45
	
		52wk Low - High
		98.79 - 121.33
	
		Previous Close
		118.65
	
		Avg. Volume
		489,430
	
		Industry
		MED PRODUCTS
	
		Market Cap
		11.15 B
	
		Div - Yield
		0.36 - 0.30
	
		Beta
		0.69
	
		PE (Forward)
		21.13
	
		Current Year Est.
		5.61
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		177 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/8/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            21.13
                        
                            PEG Ratio
                            1.67
                        
                            Current Year Est.
                            5.61
                        
                            Current Quarter Estimate
                            1.58
                        
                            Most Accurate Estimate
                            1.58
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-15-2013
                        
                            EPS Last Year
                            5.33
                        
                            Expected Earnings Growth
                            12.68%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Perrigo Company, is the nations largest manufacturer of store brand over-the-counter (non-prescription) pharmaceutical products and also manufactures store brand nutritional products. Store brand products are sold by national and regional supermarket, drugstore and mass merchandise chains under their own labels and compete with nationally advertised brands.  The Company's products include analgesics, cough and cold remedies, antacids, laxatives, feminine hygiene and smoking cessation products, and vitamins, nutritional supplements and nutritional drinks.   
Full PRGO Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
PRGO Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (06/2013)	Next Year (06/2014)
Average Estimate	1.58	1.47	5.61	6.62
Number of Estimates	16	8	16	16
Low Estimate	1.51	1.22	5.55	6.20
High Estimate	1.66	1.61	5.70	NA
Year Ago EPS	1.28	1.27	4.99	5.61
EPS Growth	23.10%	15.94%	12.53%	17.95%

More PRGO Estimates

Average Earnings Estimates for PRGO

EPS Growth for PRGO

Industry Analysis

Name	Symbol	Previous Close
PERRIGO COMPANY	PRGO	118.65
CONCEPTUS INC	CPTS	30.98
ATRICURE INC	ATRC	8.99
INVIVO THERAPT	NVIV	2.90
TRANS1 INC	TSON	1.59
ABAXIS INC	ABAX	44.22
ADVAXIS INC	ADXS	0.05
BAXTER INTL	BAX	73.04
BIO-RAD LABS -A	BIO	116.12
BIOLIFE SOL INC	BLFS	0.38

Sector:Medical>> Industry:MED PRODUCTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Earnings Miss at Perrigo

May 07, 2013

Perrigo Likely to Report In Line Earnings

May 06, 2013

Covidien's 2Q Earnings Beat

Apr 26, 2013

Stryker's 1Q Earnings Beat Est.; Sales Lag

Apr 25, 2013

Covidien Collaborates with VIDA

Apr 17, 2013

St. Jude's 1Q Earnings In Line

Apr 17, 2013

Perrigo Touches 52-Week High

Apr 03, 2013

Perrigo Buys Velcera

Apr 02, 2013

More PRGO Zacks Commentary

Financials

EPS TTM	5.33
Sales	3,173
Net Income	431
Price/Earnings	22.26
Price/Book	5.01
Price/Cash Flow	18.33
Price/Sales	3.28

More PRGO Financials

News

Earnings Look Back: Perrigo Is Up 2.7% Since Reporting Quarterly Results 1 Week Ago (PRGO) - Comtex Smartrend(R)

May 20, 2013

Perrigo reports lower Q3 net income, provides outlook for fiscal 2013 - Datamonitor

May 20, 2013

VO, VXF, PRGO, AKR, HSP, PNRA Are Seasonally Ripe To Go Up In the Next Five Weeks - M2

May 20, 2013

Perrigo Earnings Review: 11 Days after Announcement Shares Up 2.7% (PRGO) - Financial News Network Online - Earnings Lookback

May 18, 2013

The New Generic-Drug Battle Front - TheMotleyFool

May 18, 2013

Perrigo (PRGO) Could Fall Through $118.93 Support Level - Freshbrewedmedia

May 17, 2013

Shares of Perrigo Rise to a New 52-Week High - Financial News Netwfork Online - 52-Week High-Lows

May 15, 2013

Perrigo (PRGO) Showing Resistance Near $121.29 With 0.30% Dividend Yield - Freshbrewedmedia

May 13, 2013

See All News Stories on PRGO

Broker Recommendations

Current ABR	1.74
ABR (Last Week)	1.74
# of recs in ABR	17
Average Target Price	127.29
Industry Rank by ABR	177 out of 265
Rank in Industry	5 out of 73

More PRGO Broker Recommendations

Day Low - High	117.25 - 120.45
52wk Low - High	98.79 - 121.33
Previous Close	118.65
Avg. Volume	489,430
Industry	MED PRODUCTS
Market Cap	11.15 B
Div - Yield	0.36 - 0.30
Beta	0.69
PE (Forward)	21.13
Current Year Est.	5.61
Quarterly Earnings ESP	0.00%

PE (Forward)	21.13
PEG Ratio	1.67
Current Year Est.	5.61
Current Quarter Estimate	1.58
Most Accurate Estimate	1.58
Earnings ESP	0.00%
Next Earnings Report Date	08-15-2013
EPS Last Year	5.33
Expected Earnings Growth	12.68%

Username: Password:

Remember me [?]

Perrigo Co: (NASD: PRGO)

$118.07

-0.58 (-0.49%)

Volume 504,348

May 22 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED PRODUCTS

Zacks Commentary

Financials

News

Broker Recommendations